| Term es nes pval sidak fdr geneset_size leading_edge leading_edge_size |
| Alzheimers disease and mirna effects 0.4652148336405161 2.8014485115807735 0.0050873758621219 0.9521562567553036 0.063168250288014 82 Q92542,P21796,P45880,P05141,Q13564,Q8NEB9,P12236,P48556,Q08752,O95197,Q9Y277,O43242,O00487,Q96IX5,Q13885,P62195,P16615,O14818,P07437,Q9BUF5,P49721,P62191,P43686,Q9UNM6,P60900,P04406,P17980,Q9NQC3,P28066,P51665,P33176,P28072,P14735 33 |
| Parkinubiquitin proteasomal system pathway 0.588484314971284 2.7937577234723627 0.0052099495535642 0.9555436257273692 0.063369998651516 35 P22314,O00231,Q13616,P48556,Q9Y385,O14936,O43242,O00487,Q13200,Q13885,P62195,Q15008,P34932,P07437,Q9BUF5,P0DMV9,P62191,P43686,P35998,Q9UNM6,P68036,P17980,P51665,O75832,P54652,P55036 26 |
| Alzheimers disease 0.4609122865450593 2.72415661169938 0.0064465929068442 0.978818080332869 0.0735334595538006 81 Q92542,P21796,P45880,P05141,Q13564,Q8NEB9,P12236,P48556,Q08752,O95197,Q9Y277,O43242,O00487,Q13885,P62195,P16615,O14818,P07437,Q9BUF5,P49721,P62191,P43686,Q9UNM6,P60900,P04406,P17980,Q9NQC3,P28066,P51665,P33176,P28072,P14735 32 |
| Proteasome degradation 0.5328751237687614 2.5574117374702285 0.0105454315602684 0.998197267074794 0.1130918280546728 40 P22314,O00231,P48556,O43242,Q13200,P62195,Q15008,O14818,P10321,P49721,P62191,P43686,P25786,P35998,P61289,Q9UNM6,P60900,Q06323,P17980,P28066,P51665,P28072,P04843,Q9UL46 24 |
| Photodynamic therapyinduced nfe2l2 nrf2 survival signaling 0.8857594936708856 2.411585578522393 0.0158833238450299 0.9999282588543152 0.156058392624559 2 P09601 1 |
| Tlr4 signaling and tolerance 0.8655063291139232 2.323595839984924 0.0201471656088685 0.9999946065267848 0.1835013146422984 2 Q15629 1 |
| Mitochondrial complex iv assembly 0.6711163650702515 2.3152181352257335 0.0206009972655323 0.9999959078094384 0.1835013146422984 16 P13073,P14406,Q9Y2R0,Q9Y241 4 |
| Overview of nanoparticle effects 0.8458860759493665 2.2375990137160446 0.0252472159387766 0.9999997595013562 0.2061279547878203 2 P09601 1 |
| Electron transport chain oxphos system in mitochondria 0.4679862810882794 2.1896025501619065 0.0285530739167307 0.9999999682480268 0.2181747699278403 56 P13073,O43676,P14406,O95298,O75306,O75880,Q9UDW1,Q7KZN9,P12236,O75964,P24539,O14949,P03886 13 |
| Ferroptosis 0.5769617682723654 2.157395738001893 0.0309748430292673 0.9999999928271628 0.2307625805680417 22 P45880,Q9NZ45,P09601,Q9Y277 4 |
| Translation factors 0.509123513838024 2.123895255228485 0.0336789032460098 0.9999999986435903 0.2418388715014684 34 P06730,P29692,P24534,O75153,P26641,P49770,O00303,Q13347,P63241,Q14240,P62495,Q13144,O15371,O15372 14 |
| Aflatoxin b1 metabolism 0.7971518987341764 2.020861763558965 0.0432940770222507 0.9999999999965008 0.2897284987043529 2 P07099 1 |
| Sphingolipid pathway 0.7200420913938533 2.011837500680298 0.0442370694330471 0.999999999998056 0.2897284987043529 10 Q13510,P04062,Q06136,O95470,Q96G23 5 |
| Eicosanoid synthesis 0.8841405508072153 1.9404014644584069 0.0523309187658656 0.9999999999999878 0.3092569669048112 3 P09960,Q9NP80 2 |
| Sphingolipid metabolism in senescence 0.6600953670119027 1.9231807252619748 0.0544573570427266 0.9999999999999968 0.3092569669048112 12 Q13510,P04062,Q06136,P78345,P16278,Q96G23,Q16739 7 |
| Sphingolipid metabolism integrated pathway 0.7313430166108326 1.874645108579181 0.0608415630954637 1.0 0.3326749688522604 8 O95470,Q13510,Q06136,Q96G23 4 |
| Sphingolipid metabolism overview 0.7313430166108326 1.874645108579181 0.0608415630954637 1.0 0.3326749688522604 8 O95470,Q13510,Q06136,Q96G23 4 |
| Vitamin a and carotenoid metabolism 0.8531066352454817 1.8173003993707704 0.0691711288607266 1.0 0.355664326829498 3 Q8WTV0 1 |
| Metabolism of spingolipids in er and golgi apparatus 0.849905003166567 1.8036751800848565 0.0712822426774517 1.0 0.355664326829498 4 O95470,Q10472,Q06136 3 |
| Spinal cord injury 0.5362251030174603 1.801587895242056 0.0716102671468787 1.0 0.355664326829498 20 P08670,Q08722,P14174,P06493,Q9NQC3,P62942 6 |
| Cholesterol metabolism with bloch and kandutschrussell pathways 0.5055419271562596 1.7063663684202484 0.0879398882526538 1.0 0.3911356223774754 23 O76062,Q15800,Q16850,Q15392,Q14739 5 |
| Cori cycle 0.6066247807954023 1.6404529210601595 0.100911029578905 1.0 0.4205802351680239 12 P37837,P00558,P11166,P06744,P04406,P11413,P18669 7 |
| Nad metabolism 0.8072663893858371 1.633948674972368 0.1022696279935295 1.0 0.4232826269732195 4 P43490 1 |
| Amyotrophic lateral sclerosis als 0.654227067787315 1.5998615473217466 0.1096293013745519 1.0 0.4444834259811766 9 Q9UER7,Q9BUN8,P07196 3 |
| Mitochondrial complex iii assembly 0.652943955918839 1.5936621767121526 0.1110117201201847 1.0 0.4470471972407441 9 O14949,Q9UDW1 2 |
| Genes related to primary cilium development based on crispr 0.7125276147998617 1.5895958688738558 0.1119259288658227 1.0 0.447703715463291 7 Q7Z392,A0AVF1 2 |
| Metapathway biotransformation phase i and ii 0.4956711250810001 1.5595250764609991 0.1188721541321169 1.0 0.4637183258996541 21 Q8NCH0,Q7LGA3,Q6UW02,P07099,P21964,Q16850,P78417 7 |
| Aryl hydrocarbon receptor pathway wp2873 0.7464212862663192 1.549666790404074 0.121221512960328 1.0 0.4678668804369094 6 Q07812,Q15185,Q16543 3 |
| Signal transduction through il1r 0.6936708860759478 1.547773705338756 0.1216767893753707 1.0 0.4678668804369094 2 Q15750 1 |
| Heme biosynthesis 0.7609982019190741 1.5313216300239192 0.1256899223143843 1.0 0.4784104551304219 5 P06132,P22830 2 |
| Oxidation by cytochrome p450 0.7606687634382712 1.5299696939276022 0.1260242306299936 1.0 0.4784104551304219 5 Q16850,P16435,O43169 3 |
| Ciliary landscape 0.344318335362174 1.5153672635222717 0.1296794228932751 1.0 0.4793851164190696 98 Q9UNS2,Q92905,Q9BT78,P16278,Q6NTF9,P48556,Q9HDC9,Q92600,O15173,P61019,P07196,O60343,P60660,P61106,Q9Y312,P10619,Q8TAG9,Q13409,P43686,Q9UPT5,Q9Y6G9,Q9H4A3,Q16795,P08670,O95400,Q9UNM6,Q15555,Q8IYI6,Q9Y266,P33991,P52565,P25205,Q9UBW8,Q99627,P51665,P27105,Q13576,Q14566,A0AVF1 39 |
| Myometrial relaxation and contraction pathways 0.5036180718679517 1.5129094314911176 0.1303026658722974 1.0 0.4793851164190696 19 P10644,P62258,Q04917,Q99439,Q9Y3B8,P78417,P63104 7 |
| Folatealcohol and cancer pathway hypotheses 0.684177215189872 1.5037181710477625 0.1326539484441438 1.0 0.4820838614189616 2 P11766 1 |
| Pentose phosphate metabolism 0.7450110864745029 1.465616039497844 0.1427529191032759 1.0 0.5069320330564024 5 P11413,O95336,P52209,P37837 4 |
| Nocgmppkg mediated neuroprotection 0.7609848913382262 1.447793715373857 0.1476747509218605 1.0 0.5092665630141309 4 P30536,P07196 2 |
| Tcell antigen receptor tcr pathway during staphylococcus aureus infection 0.6377860098486523 1.4393490143298564 0.150051662228597 1.0 0.5092665630141309 8 P11802,Q13153,Q12959,O95433 4 |
| Nad metabolism in oncogeneinduced senescence and mitochondrial dysfunctionassociated senescence 0.5346525771572593 1.4320335903132155 0.1521342083751358 1.0 0.5092665630141309 15 P43490,Q8IXJ6,P11166,P11413,P17174 5 |
| Vitamin d receptor pathway 0.602697833730742 1.4317357826885706 0.1522194516730883 1.0 0.5092665630141309 10 P08183,Q92783 2 |
| Cellular proteostasis 0.7216770837485118 1.288780173232268 0.1974745207327992 1.0 0.6051375915302548 4 Q99471,P61758 2 |
| Cholesterol biosynthesis with skeletal dysplasias 0.6815607716975438 1.2769088168345657 0.2016344410217483 1.0 0.6051375915302548 6 Q16850,Q15392 2 |
| Biomarkers for pyrimidine metabolism disorders 0.6415018837573492 1.273796183433504 0.2027356581200377 1.0 0.6051375915302548 7 Q9Y606,Q9H0P0,P12277,P11172 4 |
| Pregnane x receptor pathway 0.6983043484207561 1.2728639998822242 0.2030663058826358 1.0 0.6051375915302548 5 P08183,P62195 2 |
| Aerobic glycolysis 0.5478323005281992 1.234316563495291 0.217084966232059 1.0 0.6138519042815375 11 P00558,P11166,P06733,P06744,P04406,P60174 6 |
| Melatonin metabolism and effects 0.708768597657484 1.2331566119529629 0.2175173394743703 1.0 0.6138519042815375 3 P42892,Q96EB6 2 |
| Nonalcoholic fatty liver disease 0.3774856460674243 1.2274293898078847 0.2196612457704336 1.0 0.6146389787754857 52 P13073,P14406,O43676,O95298,O75306,Q9UDW1,Q86Y39,O14949 8 |
| Adipogenesis 0.4878112832918687 1.219822591130064 0.2225321354489136 1.0 0.6181172845172388 16 P43490,Q9NZ45 2 |
| Methionine de novo and salvage pathway 0.5892210467221001 1.209341272228148 0.2265317608562744 1.0 0.6196478195527682 8 Q13126 1 |
| Ras and bradykinin pathways in covid19 0.7019757768522716 1.209034201882372 0.2266497058095695 1.0 0.6196478195527682 4 Q99829,P28482 2 |
| Interactions between loxl4 and oxidative stress pathway 0.6941101963267883 1.1772278623815438 0.2391045706220715 1.0 0.6390418120661644 4 Q8TAG9,Q96EB6,Q16543 3 |
| Ebsteinbarr virus lmp1 signaling 0.6929408040519123 1.1687645020075372 0.2424985261027035 1.0 0.6411804676680475 3 P28482,P07900 2 |
| Ccl18 signaling pathway 0.5350714769283068 1.1671936102495322 0.2431321907600314 1.0 0.6411804676680475 11 P11166,P33176,P07196,Q86UE4 4 |
| Purine metabolism 0.5700086427923866 1.1182310403198208 0.2634683303932803 1.0 0.6797711035255197 8 P07741,P00813,P00492,P30520,P30566 5 |
| Hostpathogen interaction of human coronaviruses apoptosis 0.6719604113410137 1.0878682005548357 0.2766532961513448 1.0 0.70325904795758 4 Q07812 1 |
| Nad biosynthetic pathways 0.648151640204596 1.0659961583323276 0.2864253785239199 1.0 0.714265797490612 5 P43490 1 |
| Glucuronidation 0.6275453172285637 1.049355980684385 0.2940143099451391 1.0 0.7271059283290577 6 Q96G03,P36871 2 |
| Aryl hydrocarbon receptor pathway wp2586 0.6178364476197311 1.0086917990685058 0.3131224660492906 1.0 0.747987877118883 6 P28482,P07900,Q16543 3 |
| Mrna protein and metabolite inducation pathway by cyclosporin a 0.5772151898734155 1.0073776986086225 0.3137533041606053 1.0 0.747987877118883 2 Q15758 1 |
| Oxidative phosphorylation 0.3780923516429195 0.999318145154824 0.317640598183202 1.0 0.7536628268902219 33 O95298,O75306,O75964,Q86Y39,P24539,P03886 6 |
| Hif1a and pparg regulation of glycolysis 0.6438051581986692 0.9750514997797064 0.3295347147826173 1.0 0.7652119288253384 4 P04406,P11166 2 |
| Tryptophan metabolism 0.4597395158815739 0.9312485314524686 0.3517250188054484 1.0 0.7895174801975667 14 P51648 1 |
| Cholesterol biosynthesis pathway 0.4758458367641125 0.9306282015645746 0.3520459211768334 1.0 0.7895174801975667 12 Q16850,P14324,Q15800 3 |
| Proximal tubule transport 0.4898663442612983 0.9302977822056648 0.3522169257995184 1.0 0.7895174801975667 11 P08183,P11166 2 |
| Endochondral ossification 0.5592691456470955 0.908162429906423 0.3637924104609424 1.0 0.7915346365851736 7 Q9Y376,P08069 2 |
| Endochondral ossification with skeletal dysplasias 0.5592691456470955 0.908162429906423 0.3637924104609424 1.0 0.7915346365851736 7 Q9Y376,P08069 2 |
| Hijack of ubiquitination by sarscov2 0.626265790229189 0.905460421287818 0.3652215185585952 1.0 0.7915346365851736 4 Q13564 1 |
| Pentose phosphate pathway in senescent cells 0.5924176972202447 0.8396608314536246 0.4010985812149665 1.0 0.8401034771419384 5 P11413,O95336,P37837 3 |
| Familial partial lipodystrophy fpld 0.5048105760355962 0.8126127424251209 0.416440123489286 1.0 0.8541422637624589 8 O75844,P49354 2 |
| Erk pathway in huntingtons disease 0.6016466117796021 0.8090743446787796 0.4184723842594597 1.0 0.8541422637624589 4 P42858,P42574,P28482 3 |
| Calcium regulation in cardiac cells 0.3675191341945238 0.7914741155831259 0.4286673750787819 1.0 0.8660534086337426 27 P10644,P62258,P16615,Q04917,P23634,P31946,Q9Y3B8,P62942,P09471,P63104 10 |
| Glucocorticoid receptor pathway 0.5590111793098577 0.7664265642179129 0.4434225317212594 1.0 0.8869190027562914 6 Q15185,P27105,P07900 3 |
| Allograft rejection 0.4705972823877465 0.7663644130339886 0.4434595013781457 1.0 0.8869190027562914 10 P08183,P08670 2 |
| Initiation of transcription and translation elongation at the hiv1 ltr 0.4931164014062461 0.759061731330882 0.4478156300341436 1.0 0.8926358377938113 8 Q8IXH7,Q9H3P2,P18615,P50750 4 |
| Tnfalpha signaling pathway 0.3947692062713873 0.7414790040425517 0.4584030576239348 1.0 0.9020399293677788 18 Q13200,Q16543,Q07812,Q15750,P63208,P28482,P07900 7 |
| Proteoglycan biosynthesis 0.5660874308102769 0.7356027914508794 0.4619724632900639 1.0 0.9020399293677788 5 Q8NCH0 1 |
| Mir124 predicted interactions with cell cycle and differentiation 0.5132911392405038 0.7217432248780157 0.4704523614340825 1.0 0.9020399293677788 2 Q13131 1 |
| Progeriaassociated lipodystrophy 0.4550069434397708 0.6906296090515801 0.4897983353313093 1.0 0.9144930414274391 10 O75844 1 |
| Regulation of actin cytoskeleton 0.324188699613455 0.6861244047904821 0.4926346625477569 1.0 0.9144930414274391 39 P35241,P15311,Q13177,Q92888,Q8NEB9,Q9Y281,P26038,P18206,Q9UQB8,Q13153 10 |
| Eukaryotic transcription initiation 0.4078647467869584 0.681419435880168 0.4956061281561457 1.0 0.9144930414274391 15 Q9GZS1,Q13418,Q00403 3 |
| Notch signaling 0.4983781952321819 0.6473798220670496 0.51738615184393 1.0 0.9344307469666128 7 Q92542,Q06330,O14641,Q13363 4 |
| Mitochondrial complex i assembly model oxphos system 0.3468328920726007 0.6374197482604269 0.5238514682962312 1.0 0.9390893683011536 27 O43676,O95298,O75306,Q9Y6M9,Q96CU9,Q9NPL8,P03886 7 |
| Cannabinoid receptor signaling 0.5348600042803775 0.616086057786997 0.5378377233826375 1.0 0.9505542296476048 5 Q8NCG7,P10644 2 |
| Mitochondrial complex ii assembly 0.55062223384012 0.611593222256681 0.5408069234977453 1.0 0.9505542296476048 3 P21912 1 |
| Hepatitis b infection 0.3593095289435722 0.6097650769757009 0.5420174386242413 1.0 0.9505542296476048 21 Q07812,Q15750,P51692,P31946,P12004,P63104,Q9Y277 7 |
| Canonical and noncanonical notch signaling 0.4816455696202506 0.5887791345552768 0.5560094445852899 1.0 0.966127198171524 2 Q06330 1 |
| Factors and pathways affecting insulinlike growth factor igf1akt signaling 0.4787108286181122 0.5671978354939877 0.5705797784607081 1.0 0.9771819866797452 7 Q13418,P49770,P08069 3 |
| Melanoma 0.4054178546900209 0.5614842674918381 0.5744674523493329 1.0 0.9771819866797452 12 Q07812,Q13153,P18206 3 |
| Ciliopathies 0.3926433888002103 0.557585271347526 0.5771276162940777 1.0 0.9771819866797452 14 O43924,Q9UBB4 2 |
| Envelope proteins and their potential roles in edmd physiopathology 0.3751829468153876 0.5399064604293449 0.5892615423161471 1.0 0.9856481495972426 16 P33176,Q14739 2 |
| Glycolysis in senescence 0.4220317678959792 0.5358671075377881 0.5920503985835786 1.0 0.9856481495972426 10 P11413,P00558,P04406 3 |
| Apoptosis 0.3994658962350323 0.5319489060449973 0.594761383633289 1.0 0.9864227534214044 12 Q07812,P08069 2 |
| Angiotensin ii receptor type 1 pathway 0.5259886584206173 0.5240903413357845 0.6002157061293407 1.0 0.9864227534214044 3 P28482 1 |
| Physicochemical features and toxicityassociated pathways 0.390874589949194 0.5165103965154675 0.6054979795888045 1.0 0.9864227534214044 13 P61160,O75116,P28482,Q13153,P07196 5 |
| Glycogen synthesis and degradation 0.3583470996178516 0.5161405410213766 0.6057562546178423 1.0 0.9864227534214044 18 Q16851,P46976,P30154,Q15257,P52789,P36871,P49841,P13807 8 |
| Nephrotic syndrome 0.3819461661005873 0.5014478406492209 0.6160559777435455 1.0 0.9923496290139272 14 Q14108 1 |
| Inflammatory response pathway 0.4566455696202504 0.4899074787705534 0.6241993706297952 1.0 0.9936956308010144 2 P11047 1 |
| Cysteine and methionine catabolism 0.4955895898550761 0.4743033067789314 0.6352836337892223 1.0 1.0 5 P17174,P25325,Q99707 3 |
| Striated muscle contraction pathway 0.4922306318819093 0.4627288663887529 0.6435587244844494 1.0 1.0 5 P08670 1 |
| Purine metabolism and related disorders 0.3795600828251119 0.4601371029807433 0.6454178137468429 1.0 1.0 13 P07741,P00813,P00492,P30520,P30566,P00491 6 |
| Vasopressinregulated water reabsorption 0.3585355378684992 0.4477415185535616 0.654339753911289 1.0 1.0 16 Q13409,P52565,Q12846,P61020,Q14203 5 |
| Camkk2 pathway 0.3914723321943681 0.4439833478065039 0.6570546233321122 1.0 1.0 11 P09601 1 |
| Mitochondrial immune response to sarscov2 0.4007793431607325 0.4414688548920041 0.6588736042224768 1.0 1.0 10 Q9Y6M9,Q9Y375,Q99623,P35232 4 |
| Integrinmediated cell adhesion 0.3311570701398514 0.4154316650808287 0.6778259301894043 1.0 1.0 20 P04632,Q13153,P18206 3 |
| Regulation of apoptosis by parathyroid hormonerelated protein 0.4582364662290852 0.3897654796218494 0.6967099722098995 1.0 1.0 6 Q07812,P49841,Q9BXK5,Q07820 4 |
| Neural crest cell migration during development 0.4555915664047081 0.3809947847234857 0.7032071184085495 1.0 1.0 6 Q13153 1 |
| Endothelin pathways 0.4270288116434651 0.371996657673325 0.7098953378607169 1.0 1.0 7 P42892,P28482,P16615 3 |
| Photodynamic therapyinduced ap1 survival signaling 0.4454058633317129 0.3479343593870329 0.7278894804670069 1.0 1.0 6 Q07812,Q07820 2 |
| Overlap between signal transduction pathways contributing to lmna laminopathies 0.3447986719908744 0.3443506465228399 0.7305826000987199 1.0 1.0 15 P11802,P55209,O75844,P49354,P42167 5 |
| Head and neck squamous cell carcinoma 0.3546757269939558 0.3426038793067321 0.731896483255901 1.0 1.0 13 P11802,P62942,P08069 3 |
| Pilocytic astrocytoma 0.4132911392405032 0.3359612981088343 0.7369000514942017 1.0 1.0 2 P62993 1 |
| Constitutive androstane receptor pathway 0.4395342666273381 0.3294158402188053 0.7418413965615569 1.0 1.0 6 P08183,Q15257 2 |
| Ketogenesis and ketolysis 0.4375057801834744 0.3231135307985074 0.7466092633320038 1.0 1.0 6 P23786,O43772 2 |
| Somatroph axis gh and its relationship to dietary restriction and aging 0.4577230989683549 0.3092046322118625 0.7571658704536861 1.0 1.0 3 P08069 1 |
| Acquired partial lipodystrophy barraquersimons syndrome 0.4428061675609536 0.3052881170856254 0.7601467254211227 1.0 1.0 5 P20700,P49354,P02545 3 |
| Pyrimidine metabolism and related diseases 0.4051828805704067 0.2984421965602017 0.7653656873462713 1.0 1.0 7 Q9H0P0,Q05682,P11172 3 |
| Neural crest cell migration in cancer 0.4049313384648103 0.2976325314735003 0.765983642678097 1.0 1.0 7 Q13153 1 |
| Sars coronavirus and innate immunity 0.3984177215189844 0.2894166214766301 0.7722625769024567 1.0 1.0 2 Q7Z434 1 |
| Relationship between inflammation cox2 and egfr 0.4482330946996706 0.285385921325539 0.7753484924170155 1.0 1.0 4 Q9H7Z7 1 |
| Map3k1 role in promoting and blocking gonadal determination 0.4312665599195345 0.2725324449429615 0.7852126475868852 1.0 1.0 5 P28482,Q13464 2 |
| Notch signaling pathway 0.3245999990735514 0.2309466363160611 0.8173562593613686 1.0 1.0 14 Q92542,Q13616,Q06330,Q13573,P49841,P63208 6 |
| Urea cycle and metabolism of amino groups 0.3740697914974156 0.2054724448865704 0.8372030245922004 1.0 1.0 7 P12277,P52788 2 |
| Kallmann syndrome 0.4134219689775155 0.1987228782842985 0.8424795266548151 1.0 1.0 3 P28482,P62993 2 |
| Burn wound healing 0.3415977939631199 0.1910108040230083 0.8485171286169773 1.0 1.0 9 P31949,P08670,Q99439 3 |
| Hostpathogen interaction of human coronaviruses interferon induction 0.3985438429882793 0.1677228732545925 0.8668013008399549 1.0 1.0 3 P19525,Q7Z434 2 |
| Type i interferon induction and signaling during sarscov2 infection 0.3985438429882793 0.1677228732545925 0.8668013008399549 1.0 1.0 3 P19525,Q7Z434 2 |
| T cell receptor and costimulatory signaling 0.3947451725229455 0.1603237629895432 0.8726260408308208 1.0 1.0 3 P49841,P49840 2 |
| Sterol regulatory elementbinding proteins srebp signaling 0.2671775565210903 0.1518841846084467 0.8792782824210374 1.0 1.0 31 Q14534,P14324,Q15437,Q16850,O95486,Q96EB6,Q8WTV0 7 |
| Nitric oxide metabolism in cystic fibrosis 0.3901203293223414 0.1502786287349496 0.8805447933021755 1.0 1.0 4 O14744,O60678,Q86X55 3 |
| Il1 signaling pathway 0.350925039459761 0.146548686150548 0.8834882587595494 1.0 1.0 7 P61088,Q15750,P28482 3 |
| Micrornas in cardiomyocyte hypertrophy 0.2909185121164368 0.1303425755508926 0.8962953969444174 1.0 1.0 16 Q15750,O75116,P08069,Q13464,P28482,P50750,Q13144 7 |
| Deregulation of rab and rab effector genes in bladder cancer 0.3310126582278446 0.127461440872602 0.8985751899354619 1.0 1.0 2 Q9BXI6 1 |
| Wnt signaling 0.2968901410145985 0.1171755744019669 0.9067209223661672 1.0 1.0 13 Q8TAA9,P49841,O75116,Q13363 4 |
| Nsp1 from sarscov2 inhibits translation initiation in the host cell 0.2960815721877697 0.1146029857430651 0.9087598130243062 1.0 1.0 13 P60228,O00303,P55884,Q13347,O75821,O75822,O15371,O15372 8 |
| Transsulfuration pathway 0.3478252481661638 0.1021510428756164 0.9186367865204454 1.0 1.0 6 P17174,P25325,Q99707 3 |
| Nonsmall cell lung cancer 0.2937115629995208 0.1018715545317229 0.9188586286675562 1.0 1.0 12 Q07812,P11802,P51692 3 |
| Pdgf pathway 0.2930158730158663 0.0998523809627272 0.920461521816338 1.0 1.0 12 P40763,P12931,P61586,P42224,P63000,P28482,P00403,P62993,P60953,Q13153,Q06124 11 |
| Apoptosis modulation and signaling 0.2824793400797856 0.0993859481587443 0.9208318392684292 1.0 1.0 16 Q07812,P04632,Q9UER7 3 |
| Measles virus infection 0.2633111356329976 0.0978129639002473 0.9220808130452848 1.0 1.0 24 P11802,Q07812,P51692,P63244,P26038,P54652,P0DMV9,O15372 8 |
| Nucleotidebinding oligomerization domain nod pathway 0.3260825881738779 0.0938682238863874 0.9252138360186466 1.0 1.0 7 Q9P0J0 1 |
| Leukocyteintrinsic hippo pathway functions 0.3490655685777684 0.0936189353988481 0.9254118674031536 1.0 1.0 5 Q15561,P63000,P27348,P61586 4 |
| Tca cycle in senescence 0.3256157370461583 0.0929854342846786 0.9259151328410486 1.0 1.0 7 P48163 1 |
| Il17 signaling pathway 0.3524925309051988 0.0885283619035588 0.9294567432903412 1.0 1.0 4 P28482 1 |
| Acute viral myocarditis 0.2691695832007674 0.0830151828559423 0.9338394671118851 1.0 1.0 19 P40763,Q14249,P11940,P12931,Q07812,P78310,P55210,P42224,Q9NRG0,Q13418,P28482,P09874,P78344,O00273,P49841,P42574,Q04637,P27361 18 |
| Methionine metabolism leading to sulfur amino acids and related disorders 0.3423052564914489 0.075312380637815 0.93996617113475 1.0 1.0 4 P23526,P55263,Q99707 3 |
| Neovascularisation processes 0.2920886075949334 0.0723263328685719 0.942342208971354 1.0 1.0 2 P28482 1 |
| Resistin as a regulator of inflammation 0.2920886075949334 0.0723263328685719 0.942342208971354 1.0 1.0 2 P28482 1 |
| Serotonin receptor 467 and nr3c signaling 0.2920886075949334 0.0723263328685719 0.942342208971354 1.0 1.0 2 P28482 1 |
| Omega9 fatty acid synthesis 0.3273130544993622 0.0692029121088133 0.944828105139492 1.0 1.0 6 P33121,O95864,O00767,O95573,P49327 5 |
| Il9 signaling pathway 0.295363003299994 0.0672459685412882 0.9463858903150388 1.0 1.0 8 P51692,P50750 2 |
| Tnfrelated weak inducer of apoptosis tweak signaling pathway 0.2901077996195365 0.0578643123805529 0.953856710064532 1.0 1.0 8 P55210,P63000,P28482,Q13547,P49841,P42574,P27361 7 |
| Glycolysis and gluconeogenesis 0.2504644325122432 0.0529767671954684 0.9577504188054284 1.0 1.0 26 P17858,P00558,O95563,P11166,P06733,P06744,P52789,P09622,P04406,P18669,P17174 11 |
| Network map of sarscov2 signaling pathway 0.2494913374740242 0.0504178643847909 0.9597894007694748 1.0 1.0 27 P60520,Q99829,P06493,Q14240,Q9P253 5 |
| Il4 signaling pathway 0.282270853155724 0.0471412155615479 0.9624006785671464 1.0 1.0 9 P40763,P42224,P28482,P21333,P62993,P27361,P51692,Q06124 8 |
| Integrated cancer pathway 0.2718779109973581 0.0460377158116572 0.9632801888946824 1.0 1.0 13 Q07812,P11802,P43246,P06493 4 |
| Purinergic signaling 0.3096896770107711 0.0423189907360241 0.9662444064286412 1.0 1.0 4 P63096,P09471,P08754 3 |
| Epo receptor signaling 0.2925515055467571 0.0404116746064857 0.9677649228632552 1.0 1.0 7 P40763,P12931,P42224,P28482,P62993,P51692 6 |
| Serotonin htr1 group and fos pathway 0.2925515055467568 0.0404116746064852 0.9677649228632556 1.0 1.0 7 P63096,P61586,P04899,P28482,P08754,P09471 6 |
| Mapk cascade 0.2921810699588474 0.0369978102333415 0.9704867517272936 1.0 1.0 3 P28482,P62993 2 |
| Tca cycle nutrient use and invasiveness of ovarian cancer 0.2921810699588445 0.0369978102333398 0.970486751727295 1.0 1.0 3 P40763,P28482 2 |
| Heart development 0.2896486229819563 0.0355822781854738 0.971615439332346 1.0 1.0 3 P28482,Q06124 2 |
| Regucalcin in proximal tubule epithelial kidney cells 0.2990147090272913 0.0344586041262791 0.9725114518510434 1.0 1.0 6 Q07812,P28482 2 |
| Pdgfrbeta pathway 0.2924588086185019 0.0280684209213178 0.9776075805993298 1.0 1.0 6 P40763,P42224,P19525,P62993,P51692 5 |
| Il7 signaling pathway 0.2820919175911304 0.0277206440504125 0.9778849584582958 1.0 1.0 7 P40763,P51692,P42224,P28482,P49841,P27361 6 |
| Circadian rhythm genes 0.23432553768701 0.0223795843374964 0.9821451656121531 1.0 1.0 42 P11802,Q8WXF1,P00813,P43490,Q9NRV9,P50416,Q96EB6,Q05086,Q06210,P63208 10 |
| Bladder cancer 0.2819132087424812 0.0211497539892235 0.9831261958127108 1.0 1.0 5 P11802,P28482,P12931,P04637 4 |
| Type 2 papillary renal cell carcinoma 0.2639606877794583 0.0193492496984605 0.984562495691941 1.0 1.0 8 P11166 1 |
| Tolllike receptor signaling pathway 0.2820025348542392 0.0190655812323654 0.984788788634276 1.0 1.0 6 Q15750,P42224,P63000,P28482,P27361 5 |
| Agerage pathway 0.2536112818311068 0.0180917189659736 0.9855656841796556 1.0 1.0 17 P26038,P15311,P28482,P51692 4 |
| Unfolded protein response 0.2678910702976617 0.0176839231022025 0.9858910061495914 1.0 1.0 4 P05198,Q9Y3I0,P04637 3 |
|
|
